JP2014532636A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532636A5
JP2014532636A5 JP2014537693A JP2014537693A JP2014532636A5 JP 2014532636 A5 JP2014532636 A5 JP 2014532636A5 JP 2014537693 A JP2014537693 A JP 2014537693A JP 2014537693 A JP2014537693 A JP 2014537693A JP 2014532636 A5 JP2014532636 A5 JP 2014532636A5
Authority
JP
Japan
Prior art keywords
treatment
group
medicament
virus
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014537693A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532636A (ja
Filing date
Publication date
Priority claimed from FR1159622A external-priority patent/FR2981650B1/fr
Application filed filed Critical
Publication of JP2014532636A publication Critical patent/JP2014532636A/ja
Publication of JP2014532636A5 publication Critical patent/JP2014532636A5/ja
Pending legal-status Critical Current

Links

JP2014537693A 2011-10-24 2012-10-23 ウイルス感染の処置のためのヌクレオシドアナログおよび該処置に対する感受性を評価するための方法 Pending JP2014532636A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1159622 2011-10-24
FR1159622A FR2981650B1 (fr) 2011-10-24 2011-10-24 Analogues de nucleosides pour le traitement d'une infection virale et methode d'evaluation de la sensibilite audit traitement
PCT/FR2012/052433 WO2013060980A1 (fr) 2011-10-24 2012-10-23 Analogues de nucleosides pour le traitement d'une infection virale, et methode d'evaluation de la sensibilite audit traitement

Publications (2)

Publication Number Publication Date
JP2014532636A JP2014532636A (ja) 2014-12-08
JP2014532636A5 true JP2014532636A5 (enExample) 2015-12-03

Family

ID=47221470

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014537693A Pending JP2014532636A (ja) 2011-10-24 2012-10-23 ウイルス感染の処置のためのヌクレオシドアナログおよび該処置に対する感受性を評価するための方法

Country Status (6)

Country Link
US (1) US9181294B2 (enExample)
EP (1) EP2771344B1 (enExample)
JP (1) JP2014532636A (enExample)
CA (1) CA2849969A1 (enExample)
FR (1) FR2981650B1 (enExample)
WO (1) WO2013060980A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3203995A4 (en) * 2014-10-09 2019-05-15 Board of Regents of the University of Nebraska COMPOSITIONS AND METHODS OF DELIVERING THERAPY AGENTS
EP3737359A4 (en) 2018-01-12 2021-11-03 Board of Regents of the University of Nebraska ANTIVIRAL MEDICINES AND FORMULATIONS OF THEM
CA3132832A1 (en) 2018-04-09 2019-10-17 Howard E. Gendelman Antiviral prodrugs and formulations thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4924624A (en) * 1987-10-22 1990-05-15 Temple University-Of The Commonwealth System Of Higher Education 2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof
GB8921469D0 (en) * 1989-09-22 1989-11-08 Erba Carlo Spa 5'-alkylphosphonylnucleosides as antivirals
OA09370A (en) * 1990-06-21 1992-09-15 Patrick T Prendergast Irlande Administering particular compounds against various parasites, mycoplasmas, other indications and other infections.
US20030008841A1 (en) * 2000-08-30 2003-01-09 Rene Devos Anti-HCV nucleoside derivatives
KR20070004792A (ko) * 2004-03-05 2007-01-09 캠브리지 바이오테크놀로지 리미티드 아데노신 수용체 작용제

Similar Documents

Publication Publication Date Title
JP7508501B2 (ja) ヌクレオチドおよびヌクレオシド組成物ならびにこれらに関連する使用
JP7371931B2 (ja) 4’-ハロゲン含有ヌクレオチドおよびヌクレオシド治療組成物ならびにそれらに関連する使用
JP7673118B2 (ja) 化合物、組成物、及び疾患の治療方法
CA2972014A1 (en) Fused pyrimidine compounds for the treatment of hiv
JP6220484B1 (ja) フィロウイルス科ウイルス感染症を処置するための方法
JP2013056886A5 (enExample)
JP2016529324A5 (enExample)
JP2013518107A5 (enExample)
JP2016515128A5 (enExample)
WO2014124430A1 (en) Nucleotide and nucleoside therapeutic compositions and uses related thereto
ME02400B (me) Policiklična karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba
RU2015109132A (ru) Пролекарственная форма тенофовира и ее фармацевтические применения
JP2014510774A5 (enExample)
JP2017531038A5 (enExample)
JP2019526596A5 (enExample)
JP2017531619A5 (enExample)
JP2019510027A5 (enExample)
RU2010100821A (ru) Производные азапептидов
WO2017106710A1 (en) Nucleotide and nucleoside therapeutic compositions and uses related thereto
JP2011246469A5 (enExample)
JP2016513113A5 (enExample)
JP2019505529A5 (enExample)
JP2022106920A (ja) アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用
JP2024517807A (ja) ヌクレオチド及びヌクレオシド治療組成物、組合せ、並びにそれらに関連する使用
JP2014532636A5 (enExample)